Mechanisms of TWIST bHLH Transcription Factors Binding to Functional Target Regions
Project Number5SC1GM139706-04
Contact PI/Project LeaderCADILLA, CARMEN LYDIA
Awardee OrganizationUNIVERSITY OF PUERTO RICO MED SCIENCES
Description
Abstract Text
PROJECT SUMMARY
Development of the head and face constitutes one of the most complex events during
embryonic development, requiring a network of transcription factors and signaling
molecules together with proteins conferring cell polarity and cell-cell interactions.
Craniofacial abnormalities are among the most common findings in birth defects.
Transcription factors (TFs) of the helix-loop-helix (HLH) family have important roles during
human development. Mutations in the Twist subfamily of bHLH TFs result in genetic
disorders that impact the formation of mesodermal derivatives during vertebrate
embryogenesis. The basic HLH (bHLH) subfamily members can act as repressors or
activators, depending on their dimerization partner. The long-term goal of the proposed
work is to determine the molecular mechanisms by which TWIST bHLH proteins decode
genomic information, and how genetic variation modulates TWIST1/2-genome
interactions that impact craniofacial development. Mutations in TWIST1 have been shown
to cause the Saethre-Chotzen (SCS), Robinow-Sorauf (RSS), Sweeney-Cox (SwCS)
Syndromes and Craniosynostosis-1 (CRS1), while mutations in TWIST2 cause Setleis
(SS), Barber Say (BSS) and Ablepharon Macrostomia (AMS) Syndromes, all genetic
disorders that impact the development of the head and facial structures. Mutations that
affect a highly conserved Glutamate (E75 and E117 in TWIST2 and TWIST1,
respectively) in the basic region of bHLH proteins, which is responsible for nucleotide
binding in both class I and II groups, cause the most severe syndromes. The E75Q and
E75A mutations have been suggested to alter the DNA-binding activity of TWIST2,
leading to both dominant-negative and gain-of-function effects. In Specific Aim 1, we will
determine the binding affinities of TWIST1/2 and selected mutant proteins found in
patients by EMSAs, biolayer interferometry and structural studies via methods such as
circular dichroism, X-ray Crystallography, etc. In Specific Aim 2, we will determine the
DNA-sequence specificity of TWIST1 and TWIST2 complexes (as homodimers or
heterodimers with E12 as partner). We will use in vivo (ChIP) and in vitro (SELEX) DNA
binding assays combined with DNA sequencing to determine the DNA-binding specificity
of these complexes and the role that specific histone modifications (both activating and
inactivating marks) and chromatin structure (using ATAC-Seq). Bioinformatic analyses
will be performed in order to interpret changes in gene targets between wild-type and
mutant proteins and determine the TWIST binding site sequences used to regulate gene
expression of target genes. With this approach we will determine the sequences of
TWIST2 binding sites used to regulate gene expression of target genes, since there is
published evidence that missense mutations in the DNA-binding domain of TWIST2
results in altered DNA-binding. Bioinformatics analyses will be performed in order to
predict changes in gene targets between wild-type and mutant proteins. This project will
contribute to our understanding of how genetic variation contributes to normal craniofacial
development and to the craniofacial diseases caused by mutations in TWIST1 and
TWIST2 at the molecular level.
Public Health Relevance Statement
PROJECT NARRATIVE
Specific genetic disorders that cause craniofacial birth defects have been shown to be
caused by mutations in the TWIST1 and TWIST2 genes, which contain the information
for DNA-binding proteins that regulate target genes. The molecular mechanisms for the
dysfunction of these mutant TWIST2 proteins are not well understood. This project will
contribute to the understanding of how the DNA binding properties are affected in
TWIST1/2 mutant proteins and help in the identification of gene targets of these
transcription factors, the cellular pathways in which they participate and their role in
development.
No Sub Projects information available for 5SC1GM139706-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5SC1GM139706-04
Patents
No Patents information available for 5SC1GM139706-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5SC1GM139706-04
Clinical Studies
No Clinical Studies information available for 5SC1GM139706-04
News and More
Related News Releases
No news release information available for 5SC1GM139706-04
History
No Historical information available for 5SC1GM139706-04
Similar Projects
No Similar Projects information available for 5SC1GM139706-04